Remove 2012 Remove Drug Pricing Remove Insurance Coverage and Processing
article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

At the same time, the average cost of insulin for patients per year almost doubled from $2,864 to $5,705 between 2012 and 2016. Pharmacists have more insight into a patient’s insurance coverage than most providers, so this change could create a lot of value for patients throughout the country.

article thumbnail

Popping the Gross-to-Net Bubble, Part IV: Extreme Examples of Who Grew the Bubble

Pharmaceutical Commerce

Bill Roth Key Takeaways Price hikes, not launch prices, drove the GTN bubble. The real driver of the gross-to-net (GTN) bubble was the pharmaceutical industry's ability to raise drug prices year after year—enabled by loopholes in PBM contracts—rather than high launch prices alone. to $750 per pill.